We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Global COVID-19 Test Kits Market to Surpass USD 13 Billion by 2026

By LabMedica International staff writers
Posted on 23 Sep 2020
The global COVID-19 test kits market with a current market value of USD 15.4 billion in 2020 is expected to record revenue of more than USD 13 billion by 2026, driven primarily by the high efficiency and accuracy of RT-PCR based COVID-19 detection kits for the detection of the SARS-CoV-2 virus.

Given the ongoing COVID-19 pandemic, the demand for COVID-19 test kits is anticipated to surge in the near future. More...
The number of COVID-19 cases is increasing rapidly across the globe. The resumption of industrial and economic activities in high burden countries is expected to drive a further increase in the number of COVID-19 cases. These are the latest findings of Global Market Insights, Inc. (Selbyville, DE, USA), a global market research and consulting service provider.

On the basis of product, the immunoassay cassettes or test strips segment held a share of over 29% in the global COVID-19 test kits market in 2020 due to the surging demand for immunoassay-based COVID-19 detection kits, as these tests have less manufacturing costs and are easy to perform. Immunoassays can detect past infections by examining the immune response of the patient during as well as after the COVID-19 infection. On the basis of specimen type, the nasal swab segment accounted for revenue of more than USD 1.8 billion in 2020, owing to the wide availability and easy operation of nasal swab specimens.

Based on end-use, the hospitals segment dominated the global COVID-19 test kits market in 2020 with a share of around 46% Hospitals provide convenient access to quality care, manage healthcare spending and improve recovery. Competition among hospitals is continuously rising for providing better quality services at low prices.

Geographically, the COVID-19 test kits market in Asia Pacific will record a growth of -2.2% until 2026, driven by favorable government initiatives for the early treatment and diagnosis of COVID-19 in highly affected countries such as China, India as well as others. The presence of market players in Asia Pacific who are developing novel products will also boost the growth of the COVID-19 test kits market in the region.

Related Links:
Global Market Insights, Inc.


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.